This paper reviews evidence that serum total cholesterol predicts coronary heart disease (CHD) incidence or death in African American women. The NHANES I Epidemiologic Follow-up Study of over 1,000 African American women aged 25-74 and other published studies in African American women have yielded conflicting results concerning the association of serum total cholesterol and CHD. Perhaps due to the relatively small number of events in studies reviewed, the positive association of serum total cholesterol with CHD incidence in African American women was not consistently significant. Serum total cholesterol is a significant predictor of CHD risk in European American women especially at ages 25-54.
INTRODUCTION
In 1988-1994, 19 .4% of African American women, and 20.2% of European American women in the US had ageadjusted elevated serum total cholesterol concentration (>=240mg/dL), down from 24.9% and 28.0%, respectively, in [1976] [1977] [1978] [1979] [1980] (Table 1) ( 1 ). In all women, prevalence of elevated cholesterol increased from 7.3% at age 20-34 to 41.3% at 65-74 years ( 1 ). Also, coronary heart disease (CHD) mortality rates have been higher in African American than European American women in recent decades, e.g. 1997 age-adjusted death rates were 76. 6 10 ). Consistent with higher US mortality rates in African American women, data from the Third National Health and Nutrition Examination Survey (1988) (1989) (1990) (1991) (1992) (1993) (1994) revealed that prevalence of angina pectoris and self-reported myocardial infarction were higher among black than white women ( 3 ). Prevalence of myocardial infarction by electrocardiogram was the same in black and white women. In a national cohort at ages 25-54, age-adjusted incidence of CHD was higher in African American than in European American women: relative risk (RR) 1.76, 95% confidence interval 1.36-2.29 ( 10 ). However, few reports on serum total cholesterol and risk of coronary heart disease (CHD) incidence from prospective, longitudinal studies of population-based cohorts are available for African American women (   1   ,  2 ,   3   ,  4 ,   5   ,   6   ,  7 ,   8   ,   9   ,   10 , 11 , 12 , 13 , 14 , 15 ). This report will review results from the literature with an illustration from recently reported data from a national cohort which has now been followed for over 20 years ( 
). A recent report from the Charleston Heart Study found in a small cohort of African Americans that a one standard deviation increase in serum cholesterol was significantly associated with increased CHD in African American women adjusting for age (RR=1.32; 95% confidence interval (9% CI) 1.04-1.68) but only borderline significant after adjusting for multiple risk factors (RR=1.29, 95% CI 0.99-1.67) ( 4 ). . A more recent study pooling data from NHEFS and the follow-up of NHANES II also failed to demonstrate significant differences in incidence density ratio for serum total cholesterol >240 mg/dL and coronary death between black and white women ( 22 ). However, the incidence density ratio for black women, estimated from a Cox regression model, was not significantly different from 1 (95% CI 0.94-2.08). Another NHEFS analysis estimated that 4% of all coronary events adjusting for age were attributable to serum cholesterol > 240 mg/dL in black women (compared to 10% in white men) ( 11 ).
One NHEFS study focused on serum total cholesterol as a risk factor for coronary incidence and death over a 20-year follow-up in 1,046 African American women free of CHD ( 9 The prospective, cohort studies reviewed above were similar in study design, and directionality of findings. They were heterogeneous in sample size and number of endpoints, geographic region (Southeast only versus national), urbanization of subjects, and time period (1960's to 1990's) and significance of findings.
It should be noted that none of the studies reporting no significant association of serum cholesterol with CHD risk in African American women have had sufficient statistical power to exclude an important association. In such a case, a quantitative meta-analysis would be useful in aggregating the results of the smaller studies with the larger. Newer studies, such as the Jackson Heart Study, and data from large clinical trials may help shed light on this issue ( 23 ).
Cross-sectional or retrospective studies have also suggested a positive association of serum total cholesterol and CHD in African American women. One study of angiographically defined coronary artery disease in 568 African American women showed significantly higher unadjusted mean serum total cholesterol level in women with coronary stenosis (227 mg/dL) than in those without (209 mg/dL) in univariate analyses ( 24 ). In another angiographic study of 217 African American women, the unadjusted association (1 mg/dL change odds ratio=1.01, 95% CI 1.00-1.01) was no longer significant after controlling for multiple variables including history of hypercholesterolemia (odds ratio=1.0050, 95% CI 0.9979-1.0121); however this may represent over-control of confounding ( 25 ). On the other hand, the ratio of total cholesterol to HDL cholesterol was a significant independent predictor of coronary stenosis (adjusted odds ratio=1.58, 95% CI 1.2746-1.9744). In another analysis, Maynard et al. ( 26 ) found a significant association in African American women and men combined but failed to report race-, sexspecific results. A case control analysis of in black women indicated that self-reported history of elevated cholesterol was related to self-reported history of heart attack (adjusted RR=2.9, 95% CI 2.2-3.9) ( 27 ). However, substantial information bias cannot be excluded in such a study. 
CONCLUSION
In conclusion, data from the NHANES I Epidemiologic Follow-up Study and other studies revealed that the statistical significance of the association between serum total cholesterol and CHD incidence, CHD mortality, and all cause mortality in African American women, after adjustment for age and other risk factors, has not been consistent. However, in a number of studies there was a nonsignificant or inconsistently significant trend towards increased risk of CHD with elevated serum total cholesterol. Thus it seems prudent to assume that elevated serum cholesterol is a risk factor for CHD in African American women. Further cohort studies of larger numbers of African American women are needed to provide more precise estimates of the magnitude of this association for total serum cholesterol, and to examine HDL cholesterol and the ratio of total or LDL to HDL cholesterol as predictors of CHD in this group. Pooling of results from multiple studies and meta-analysis would also be productive and less expensive approaches for produce more precise estimates of effect.
